Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 3
1983 4
1984 12
1985 9
1986 5
1987 3
1988 3
1989 2
1990 2
1991 5
1992 7
1993 5
1994 7
1995 10
1996 7
1997 8
1998 4
1999 7
2000 7
2001 6
2002 1
2003 4
2004 3
2005 6
2006 5
2007 9
2008 13
2009 15
2010 14
2011 20
2012 13
2013 9
2014 14
2015 15
2016 8
2017 13
2018 14
2019 15
2020 9
Text availability
Article attribute
Article type
Publication date

Search Results

295 results
Results by year
Filters applied: . Clear all
Page 1
Current treatment strategies for advanced prostate cancer.
Komura K, Sweeney CJ, Inamoto T, Ibuki N, Azuma H, Kantoff PW. Komura K, et al. Among authors: inamoto t. Int J Urol. 2018 Mar;25(3):220-231. doi: 10.1111/iju.13512. Epub 2017 Dec 20. Int J Urol. 2018. PMID: 29266472 Free PMC article. Review.
Retraction notice to “Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers” [Biochem. Pharmacol. 79 (2010) 218–228].
Tharakan ST, Inamoto T, Sung B, Aggarwal BB, Kamat AM. Tharakan ST, et al. Among authors: inamoto t. Biochem Pharmacol. 2016 Feb 15;102:145. doi: 10.1016/j.bcp.2015.11.010. Epub 2016 Feb 20. Biochem Pharmacol. 2016. PMID: 26985467 Free PMC article. No abstract available.
Effectiveness and safety of surgical glove compression therapy as a prophylactic method against nanoparticle albumin-bound-paclitaxel-induced peripheral neuropathy.
Tsuyuki S, Yamagami K, Yoshibayashi H, Sugie T, Mizuno Y, Tanaka S, Kato H, Okuno T, Ogura N, Yamashiro H, Takuwa H, Kikawa Y, Hashimoto T, Kato T, Takahara S, Katayama T, Yamauchi A, Inamoto T. Tsuyuki S, et al. Among authors: inamoto t. Breast. 2019 Oct;47:22-27. doi: 10.1016/j.breast.2019.06.008. Epub 2019 Jul 3. Breast. 2019. PMID: 31302389
Evaluation of the effect of compression therapy using surgical gloves on nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: a phase II multicenter study by the Kamigata Breast Cancer Study Group.
Tsuyuki S, Senda N, Kanng Y, Yamaguchi A, Yoshibayashi H, Kikawa Y, Katakami N, Kato H, Hashimoto T, Okuno T, Yamauchi A, Inamoto T. Tsuyuki S, et al. Among authors: inamoto t. Breast Cancer Res Treat. 2016 Nov;160(1):61-67. doi: 10.1007/s10549-016-3977-7. Epub 2016 Sep 12. Breast Cancer Res Treat. 2016. PMID: 27620884 Clinical Trial.
MicroRNA-143/Musashi-2/KRAS cascade contributes positively to carcinogenesis in human bladder cancer.
Tsujino T, Sugito N, Taniguchi K, Honda R, Komura K, Yoshikawa Y, Takai T, Minami K, Kuranaga Y, Shinohara H, Tokumaru Y, Heishima K, Inamoto T, Azuma H, Akao Y. Tsujino T, et al. Among authors: inamoto t. Cancer Sci. 2019 Jul;110(7):2189-2199. doi: 10.1111/cas.14035. Epub 2019 May 27. Cancer Sci. 2019. PMID: 31066120 Free PMC article.
Editorial Comment from Dr Inamoto and Dr Azuma to Preclinical orthotopic xenograft model of renal pelvis cancer in which cancer growth could be traced by an in vivo imaging system.
Inamoto T, Azuma H. Inamoto T, et al. Int J Urol. 2019 Jan;26(1):140-141. doi: 10.1111/iju.13836. Epub 2018 Oct 25. Int J Urol. 2019. PMID: 30362179 Free article. No abstract available.
ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D.
Komura K, Yoshikawa Y, Shimamura T, Chakraborty G, Gerke TA, Hinohara K, Chadalavada K, Jeong SH, Armenia J, Du SY, Mazzu YZ, Taniguchi K, Ibuki N, Meyer CA, Nanjangud GJ, Inamoto T, Lee GM, Mucci LA, Azuma H, Sweeney CJ, Kantoff PW. Komura K, et al. Among authors: inamoto t. J Clin Invest. 2018 Jul 2;128(7):2979-2995. doi: 10.1172/JCI96769. Epub 2018 Jun 4. J Clin Invest. 2018. PMID: 29863497 Free PMC article.
A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
Inamoto T, Uehara H, Akao Y, Ibuki N, Komura K, Takahara K, Takai T, Uchimoto T, Saito K, Tanda N, Yoshikawa Y, Minami K, Hirano H, Nomi H, Kato R, Hayashi T, Azuma H. Inamoto T, et al. Dis Markers. 2018 Jun 20;2018:5468672. doi: 10.1155/2018/5468672. eCollection 2018. Dis Markers. 2018. PMID: 30026881 Free PMC article.
Prognostic impact of C-reactive protein-albumin ratio for the lethality in castration-resistant prostate cancer.
Uchimoto T, Komura K, Fujiwara Y, Saito K, Tanda N, Matsunaga T, Ichihashi A, Tsutsumi T, Tsujino T, Yoshikawa Y, Nishimoto Y, Takai T, Minami K, Taniguchi K, Tanaka T, Uehara H, Hirano H, Nomi H, Ibuki N, Takahara K, Inamoto T, Azuma H. Uchimoto T, et al. Among authors: inamoto t. Med Oncol. 2019 Nov 21;37(1):9. doi: 10.1007/s12032-019-1332-7. Med Oncol. 2019. PMID: 31754918
Anti-cancer Effects of a Chemically Modified miR-143 on Bladder Cancer by Either Systemic or Intravesical Treatment.
Yoshikawa Y, Taniguchi K, Tsujino T, Heishima K, Inamoto T, Takai T, Minami K, Azuma H, Miyata K, Hayashi K, Kataoka K, Akao Y. Yoshikawa Y, et al. Among authors: inamoto t. Mol Ther Methods Clin Dev. 2019 Feb 20;13:290-302. doi: 10.1016/j.omtm.2019.02.005. eCollection 2019 Jun 14. Mol Ther Methods Clin Dev. 2019. PMID: 30911586 Free PMC article.
295 results
Jump to page
Feedback